Navigation Links
MicroRNA controls mammary gland development in mice

This release is available in German.

Hormones, growth factors and several proteins ensure that development occurs in the right way, at the right time. The components that cause breast development in mammals, for example, were thought to be largely known. However, as a team of scientists from Gttingen, Frankfurt and Hanover have now discovered, in the case of breast development, hormones and proteins do not account for the full story. The scientists have shown that tiny ribonucleic acid molecules play a key role in this process. The mammary glands of mice lacking the gene for the microRNAs 212 and 132 failed to grow at puberty. (Nature Genetics, Nov. 7, 2010)

The scientists have demonstrated for the first time in an animal model that small ribonucleic acid molecules, so-called microRNAs, also fulfil an important function in organ development. "This came as a surprise to us," says project leader Kamal Chowdhury from the Max Planck Institute for Biophysical Chemistry in Gttingen. "The mice used in our experiments had all of the hormones, growth factors and proteins that ensure normal breast development. But the absence of the microRNAs miR-212 and miR-132 resulted in the complete failure of duct development in the mammary glands of mice."

It is well known that microRNAs perform very important regulatory functions inside living cells. Although they do not code for proteins, they are responsible for the fine-tuning of the production of certain proteins and intervene extensively in metabolic processes. The question is however: how does this activity shape the morphology of the whole organism? "Using various experiments, we were able to demonstrate that this RNA family plays a key role in mammary gland development and we could locate where these molecules presumably intervene on a regulatory basis," explains Chowdhury.

The mammary gland, which is also known as the milk gland, consists of the milk ducts and the surrounding connective tissue, which has a supportive and regulatory function. The connective tissue also appears to be the location where miR-212 and miR-132 are produced and intervene in the developmental process. Chowdhury and his colleague Ahmet Ucar were able to demonstrate with their experiments that this is the only place where the genes for these ribonucleic acid molecules are "switched on" in the breast tissue.

Molecular dimmer

According to the researcher's model, the microRNA molecules appear to control the production of a protein called MMP-9. "The microRNAs can down-regulate the production of MMP-9, like a dimmer switch," explains Ucar. If the microRNAs are missing, more MMP-9 proteins are produced and they accumulate near the milk ducts. They appear to activate a signalling pathway there, which prevents the normal growth of the milk ducts in the glandular tissue. "These tiny RNA molecules carry out their regulatory function by influencing the communication between the two tissues of the mammary gland," says Ucar. Other experiments now need to be carried out to examine whether these microRNAs also regulate breast development in humans. At the moment, the scientists can only speculate about what happens when the microRNAs do not function correctly. "Whether such malfunctions can lead to the formation of tumours, for example, is something that needs to be examined in further studies," says Chowdhury.


Contact: Kamal Chowdhury

Related medicine news :

1. Caltech biologists discover microRNAs that control function of blood stem cells
2. MicroRNA molecule increases number of blood stem cells, may help improve cancer treatment
3. Cancer cells show rewired, fragmented microRNA networks
4. Study links microRNA to shut-down of DNA-repair genes
5. Scientists identify microRNA as possible cause of chemotherapy resistance
6. UCLA cancer researchers discover new signaling pathway that controls cell development and cancer
7. FDA accepts historical controls for epilepsy monotherapy studies
8. Scripps Research scientists uncover previously unknown natural mechanism that controls cocaine use
9. TPG Capital Selects MetricStream GRC Platform to Boost its Internal Controls and Compliance
10. Study finds key protein controls T-cell proliferation
11. PCMA: Federal Enrollees Don't Want Congress to Reduce Pharmacy Choices, Impose Price Controls in FEHBP
Post Your Comments:
Related Image:
MicroRNA controls mammary gland development in mice
(Date:11/27/2015)... ... 2015 , ... The men and women on this list ... the country. They have overseen financial turnarounds, shown commitment to their community through ... as a whole through their advocacy and professional efforts. , Becker's Hospital Review ...
(Date:11/27/2015)... San Francisco, California (PRWEB) , ... November 27, 2015 , ... ... 1969 Janis Joplin Ann Arbor Michigan boxing style concert posters. This is one of ... 1969 at the Canterbury House at the University of Michigan in Ann Arbor. The ...
(Date:11/26/2015)... ... 2015 , ... Patients at Serenity Point Recovery, a holistic ... Thanksgiving Day to share the things that they are most grateful for today. ... channel, patients displayed what they wrote on index cards, describing the things that ...
(Date:11/26/2015)... ... November 26, 2015 , ... CognisantMD and Cambridge ... imaging in the Waterloo region. Using the Ocean Platform, family physicians can now ... their electronic medical record (EMR) without the need for redundant patient entry or ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent ... and the need to integrate dose form selection in early phase drug development. ... membership organization supporting and bringing together the UK’s emerging life sciences companies, corporate ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... Research and Markets ( ) has announced the addition ... 2019 - Rise in Cardiac Disorders and Growing Awareness among ... offering. Boston scientific and ... and others. --> The market is dominated ... scientific and others. Asia ...
(Date:11/26/2015)... , Nov. 26, 2015 Research ... addition of the "2016 Future Horizons and ... (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive ... --> --> ... analysis of the Japanese therapeutic drug monitoring market, ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the Global Cell Surface Testing ... Opportunities" report to their offering.  ... the addition of the  "2016 Future ...
Breaking Medicine Technology: